Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nalinee Sangrujee

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 14, 2012
Cost-effectiveness of tuberculosis diagnostic strategies to reduce early mortality among persons with advanced HIV infection initiating antiretroviral therapyTaiwo O Abimbola, Barbara J Marston, Anand A Date, et al.
Health Policy (Amsterdam, Netherlands)|December 19, 2006
Measles supplemental immunization activities improve measles vaccine coverage and equity: Evidence from Kenya, 2002Maya Vijayaraghavan, Rebecca M Martin, Nalinee Sangrujee, et al.
Health Affairs (Project Hope)|July 11, 2012
PEPFAR's past and future efforts to cut costs, improve efficiency, and increase the impact of global HIV programsCharles B Holmes, John M Blandford, Nalinee Sangrujee, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|December 23, 2006
Development and consideration of global policies for managing the future risks of poliovirus outbreaks: insights and lessons learned through modelingKimberly M Thompson, Radboud J Duintjer Tebbens, Mark A Pallansch, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 12, 2017
Translating Technical Support Into Country Action: The Role of the Interagency Task Team on the Prevention and Treatment of HIV Infection in Pregnant Women, Mothers, and Children in the Global Plan EraChewe Luo, Gottfried Hirnschall, Jessica Rodrigues, et al.
The Lancet. Global Health|August 9, 2014
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical modelsJeffrey W Eaton, Nicolas A Menzies, John Stover, et al.
The Lancet. Global Health|August 2, 2014
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical modelsJeffrey W Eaton, Nicolas A Menzies, John Stover, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 14, 2012
Cost-effectiveness of tuberculosis diagnostic strategies to reduce early mortality among persons with advanced HIV infection initiating antiretroviral therapyTaiwo O Abimbola, Barbara J Marston, Anand A Date, et al.
Health Policy (Amsterdam, Netherlands)|December 19, 2006
Measles supplemental immunization activities improve measles vaccine coverage and equity: Evidence from Kenya, 2002Maya Vijayaraghavan, Rebecca M Martin, Nalinee Sangrujee, et al.
Health Affairs (Project Hope)|July 11, 2012
PEPFAR's past and future efforts to cut costs, improve efficiency, and increase the impact of global HIV programsCharles B Holmes, John M Blandford, Nalinee Sangrujee, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|December 23, 2006
Development and consideration of global policies for managing the future risks of poliovirus outbreaks: insights and lessons learned through modelingKimberly M Thompson, Radboud J Duintjer Tebbens, Mark A Pallansch, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 12, 2017
Translating Technical Support Into Country Action: The Role of the Interagency Task Team on the Prevention and Treatment of HIV Infection in Pregnant Women, Mothers, and Children in the Global Plan EraChewe Luo, Gottfried Hirnschall, Jessica Rodrigues, et al.
The Lancet. Global Health|August 9, 2014
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical modelsJeffrey W Eaton, Nicolas A Menzies, John Stover, et al.
The Lancet. Global Health|August 2, 2014
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical modelsJeffrey W Eaton, Nicolas A Menzies, John Stover, et al.
Pageof 2